These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9434046)

  • 1. Skeletal effects of growth hormone and IGF-I in adults.
    Marcus R
    Horm Res; 1997; 48 Suppl 5():60-4. PubMed ID: 9434046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone and the acquisition of bone mass.
    Johannsson G; Bengtsson BA
    Horm Res; 1997; 48 Suppl 5():72-7. PubMed ID: 9434048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult growth hormone deficiency and bone mass.
    Holmes SJ; Shalet SM
    Horm Res; 1996; 45 Suppl 1():69-71. PubMed ID: 8805037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of growth hormone replacement therapy for bone mass in young adults with growth hormone deficiency.
    Attie KM
    J Pediatr Endocrinol Metab; 2000 Sep; 13 Suppl 2():1011-21. PubMed ID: 11086656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass.
    Saggese G; Baroncelli GI; Bertelloni S; Barsanti S
    J Clin Endocrinol Metab; 1996 Aug; 81(8):3077-83. PubMed ID: 8768878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal effects of growth hormone and insulin-like growth factor-I therapy.
    Lindsey RC; Mohan S
    Mol Cell Endocrinol; 2016 Sep; 432():44-55. PubMed ID: 26408965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GH and IGF-I as therapeutic agents for osteoporosis.
    Agnusdei D; Gentilella R
    J Endocrinol Invest; 2005; 28(8 Suppl):32-6. PubMed ID: 16323827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
    Joseph F; Ahmad AM; Ul-Haq M; Durham BH; Whittingham P; Fraser WD; Vora JP
    J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Growth Hormone on Bone.
    Tritos NA; Klibanski A
    Prog Mol Biol Transl Sci; 2016; 138():193-211. PubMed ID: 26940392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone and bone.
    Ohlsson C; Bengtsson BA; Isaksson OG; Andreassen TT; Slootweg MC
    Endocr Rev; 1998 Feb; 19(1):55-79. PubMed ID: 9494780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical review 61: Effects of growth hormone on human bone biology.
    Inzucchi SE; Robbins RJ
    J Clin Endocrinol Metab; 1994 Sep; 79(3):691-4. PubMed ID: 8077348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women.
    Holloway L; Kohlmeier L; Kent K; Marcus R
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1111-7. PubMed ID: 9100582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans.
    Hussain MA; Schmitz O; Mengel A; Glatz Y; Christiansen JS; Zapf J; Froesch ER
    J Clin Invest; 1994 Sep; 94(3):1126-33. PubMed ID: 8083353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD.
    Lange M; Müller J; Svendsen OL; Kastrup KW; Juul A; Feldt-Rasmussen U
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):18-23. PubMed ID: 15638865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with growth hormone and IGF-I in growing rats increases bone mineral content but not bone mineral density.
    Rosen HN; Chen V; Cittadini A; Greenspan SL; Douglas PS; Moses AC; Beamer WG
    J Bone Miner Res; 1995 Sep; 10(9):1352-8. PubMed ID: 7502707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the growth hormone replacement on bone status in growth hormone deficient adults.
    Kužma M; Kužmová Z; Zelinková Z; Killinger Z; Vaňuga P; Lazurová I; Tomková S; Payer J
    Growth Horm IGF Res; 2014 Feb; 24(1):22-8. PubMed ID: 24382377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 12 months rec-GH therapy on bone and collagen turnover and bone mineral density in GH deficient children with thalassaemia major.
    Sartorio A; Conte G; Conti A; Masala A; Alagna S; Rovasio P; Faglia G
    J Endocrinol Invest; 2000 Jun; 23(6):356-61. PubMed ID: 10908162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of growth hormone (GH) treatment on bone in postpubertal GH-deficient patients: a 2-year randomized, controlled, dose-ranging study.
    Shalet SM; Shavrikova E; Cromer M; Child CJ; Keller E; Zapletalová J; Moshang T; Blum WF; Chipman JJ; Quigley CA; Attanasio AF
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4124-9. PubMed ID: 12970274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum free insulin-like growth factor I (IGF-I), total IGF-I, and IGF-binding protein-3 concentrations in normal children and children with growth hormone deficiency.
    Kawai N; Kanzaki S; Takano-Watou S; Tada C; Yamanaka Y; Miyata T; Oka M; Seino Y
    J Clin Endocrinol Metab; 1999 Jan; 84(1):82-9. PubMed ID: 9920066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.
    Biermasz NR; Hamdy NA; Pereira AM; Romijn JA; Roelfsema F
    Clin Endocrinol (Oxf); 2004 May; 60(5):568-75. PubMed ID: 15104559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.